Page last updated: 2024-09-02

cobaltiprotoporphyrin and Congenital Zika Syndrome

cobaltiprotoporphyrin has been researched along with Congenital Zika Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araujo, DF; Assunção-Miranda, I; Bozza, MT; Carneiro, FA; Carvalho, CAM; Cruz-Oliveira, C; Da Poian, AT; Figueiredo, CM; Gomes, AMO; Higa, LM; Neris, RLS; Silva, MOL; Tanuri, A; Verçoza, BRF	1

Other Studies

1 other study(ies) available for cobaltiprotoporphyrin and Congenital Zika Syndrome

Article	Year
Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope. Scientific reports, 2018, 06-28, Volume: 8, Issue:1 Topics: Antiviral Agents; Arbovirus Infections; Arboviruses; Chikungunya Fever; Chikungunya virus; Inhibitory Concentration 50; Light; Metalloporphyrins; Protoporphyrins; Viral Envelope Proteins; Virus Inactivation; Zika Virus; Zika Virus Infection	2018

Article

Year

Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope.

Scientific reports, 2018, 06-28, Volume: 8, Issue:1

Topics: Antiviral Agents; Arbovirus Infections; Arboviruses; Chikungunya Fever; Chikungunya virus; Inhibitory Concentration 50; Light; Metalloporphyrins; Protoporphyrins; Viral Envelope Proteins; Virus Inactivation; Zika Virus; Zika Virus Infection

2018